About the Company
We do not have any company description for Senti Biosciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Senti Biosciences, Inc.
Senti Biosciences to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
PM ETSOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and ...
Senti Biosciences, Inc. Reports Progress in Phase 1 Trial of ... - Nasdaq
Senti Biosciences, Inc. announced progress in its Phase 1 clinical trial of SENTI-202 for treating Acute Myeloid Leukemia (AML), a disease that affects approximately 20,800 newly diagnosed ...
Senti Biosciences, Inc. to Present at 2025 SEED Conference on Tumor ...
Senti Biosciences, Inc., a biotechnology company focused on developing innovative cell and gene therapies, announced its participation in the 2025 Synthetic Biology: Engineering, Evolution ...
Senti Biosciences Participates in the Virtual Investor “What’s Your ...
SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and ...
Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results ...
Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights Mar. 21, 2024 4:05 PM ET Senti Biosciences, Inc. (SNTI) ...
Senti Bio Releases Mechanism of Action Video for First-in-Class Off-the ...
Investor Contact: JTC Team, LLC Jenene Thomas (908) 824-0775 SNTI@jtcir.com Source: Senti Biosciences, Inc. 2025 GlobeNewswire, Inc.
Senti Biosciences Announces New Employment Inducement Grants - FOX 2
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company innovating next-generation cell and gene therapies ...
Senti Bio Appoints Feng Hsiung to Board of Directors
SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio,” or the “Company”), a clinical-stage biotechnology company developing ...
SNTI Investors Have Opportunity to Join Senti Biosciences, Inc. Fraud ...
LOS ANGELES, May 20, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Senti Biosciences, ...
Senti Biosciences Announces New Employment Inducement Grants
SOUTH SAN FRANCISCO, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and ...
SNTI Investors Have Opportunity to Join Senti Biosciences, Inc. Fraud ...
SNTI Investors Have Opportunity to Join Senti Biosciences, Inc. Fraud Investigation with the Schall Law Firm Provided by PR Newswire May 20, 2025, 2:28:00 AM ...
Similar Companies
Loading the latest forecasts...